top of page

​Basic

  • Trisomies (an extra chromosome):

Chromosome 21 - Down syndrome

Chromosome 18 - Edward syndrome

Chromosome 13 - Patau syndrome

  • Fetal sex

(the only test in Israel that identifies the sex of each fetus separately, in twin pregnancies)

Basic Plus

  • Trisomies (an extra chromosome)

  • Fetal sex

  • Fetal sex chromosomes:

X,45 - Turner syndrome

XXY,47 - Klinefelter syndrome

XXX,47 - Triple X syndrome

XYY,47 - XYY syndrome

9503.png

What is reported by

MaterniT focus logo.jpg

Benefits of

MaterniT focus logo Bg1.jpg
medical-glove.png
blood.png

Professional and Efficient

-

The only test suitable for multiple pregnancy

Efficient in IVF twin pregnancies or surrogate pregnancies

Identifies syndromes in one or both fetuses in twin pregnancies

The only test that can identify and provide a result

in the case of fetal resorption

Dozens of centers at which the test can be performed, or by a nurse at your door

Precise and Reliable

-

The highest percentage of definitive test results

The highest rate of identification in women with

a high BMI

Only 0.9% of tests yield no results,

as opposed to 3% among competitors

clock.png

Saves you Invaluable time

-

Can be performed starting at 9 weeks pregnant

Results are received within 5 - 10 days

(14 days at the most)

Results are clear - Positive / Negative

Genetic consultation with the experts at Labcorp

Refunds from the HMOs and private insurance 

close-up-portrait-smiling-young-woman-looking-camera.png

Who is the test recommended for

  • For all women, starting at the 9th week of pregnancy.

  • For multiple pregnancies.

  • For high-risk pregnancies.

  • For women who are not interested in undergoing amniocentesis.

  • For pregnant women for whom it is important to know, at an early stage, whether the fetus has any of the common syndromes.

  • For women for whom a sense of security during pregnancy is important.

About Labcorp Genetics

Sequnom, a pioneer in non-invasive pregnancy testing - NIPT, was founded in San Diego, California, in 1994. Sequnom has developed its molecular technologies and set up a state-of-the-art genetic laboratory to perform these tests. Sequnom was acquired by the international Labcorp company, the owner of the original patents for NIPT tests. To date, these laboratories have conducted the most extensive clinical trials in the field of NIPT, a fact that confirms that they are the most experienced and reliable laboratories in the world.

לאבקורפ מעבדה ניפט nipt
bottom of page